Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew N Freedman

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Pharmacoepidemiology and Drug Safety|June 1, 2013
Trends in the use of aspirin and nonsteroidal anti-inflammatory drugs in the general U.S. populationYingjun Zhou, Denise M Boudreau, Andrew N Freedman
Cancer Discovery|May 16, 2012
Epidemiology--found in translationMargaret R Spitz, Neil E Caporaso, Andrew N Freedman
Annals of Epidemiology|November 14, 2016
Connections between pharmacoepidemiology and cancer biology: designing biologically relevant studies of cancer outcomesDonna R Rivera, Katherine A McGlynn, Andrew N Freedman
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 16, 2010
Five-year and lifetime risk of breast cancer among U.S. subpopulations: implications for magnetic resonance imaging screeningBarry I Graubard, Andrew N Freedman, Mitchell H Gail
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 6, 2010
Population prevalence of familial cancer and common hereditary cancer syndromes. The 2005 California Health Interview SurveyMaren T Scheuner, Timothy S McNeel, Andrew N Freedman
American Journal of Preventive Medicine|July 14, 2015
Targeted Cancer Screening in Average-Risk IndividualsPamela M Marcus, Andrew N Freedman, Muin J Khoury
Plos Currents|December 15, 2015
A 22 Gene-expression Assay, Decipher® (GenomeDx Biosciences) to Predict Five-year Risk of Metastatic Prostate Cancer in Men Treated with Radical ProstatectomyMichael Marrone, Arnold L Potosky, David Penson, et al.
Frontiers in Genetics|May 1, 2014
Pharmacogenomics in oncology careKelly K Filipski, Leah E Mechanic, Rochelle Long, et al.
Cancer|May 6, 2016
Prediagnostic aspirin use and mortality in women with stage I to III breast cancer: A cohort study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening TrialMarie C Bradley, Amanda Black, Andrew N Freedman, et al.
Breast Cancer Research and Treatment|May 25, 2012
Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010Erika A Waters, Timothy S McNeel, Worta McCaskill Stevens, et al.
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Pharmacoepidemiology and Drug Safety|June 1, 2013
Trends in the use of aspirin and nonsteroidal anti-inflammatory drugs in the general U.S. populationYingjun Zhou, Denise M Boudreau, Andrew N Freedman
Cancer Discovery|May 16, 2012
Epidemiology--found in translationMargaret R Spitz, Neil E Caporaso, Andrew N Freedman
Annals of Epidemiology|November 14, 2016
Connections between pharmacoepidemiology and cancer biology: designing biologically relevant studies of cancer outcomesDonna R Rivera, Katherine A McGlynn, Andrew N Freedman
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 16, 2010
Five-year and lifetime risk of breast cancer among U.S. subpopulations: implications for magnetic resonance imaging screeningBarry I Graubard, Andrew N Freedman, Mitchell H Gail
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 6, 2010
Population prevalence of familial cancer and common hereditary cancer syndromes. The 2005 California Health Interview SurveyMaren T Scheuner, Timothy S McNeel, Andrew N Freedman
American Journal of Preventive Medicine|July 14, 2015
Targeted Cancer Screening in Average-Risk IndividualsPamela M Marcus, Andrew N Freedman, Muin J Khoury
Plos Currents|December 15, 2015
A 22 Gene-expression Assay, Decipher® (GenomeDx Biosciences) to Predict Five-year Risk of Metastatic Prostate Cancer in Men Treated with Radical ProstatectomyMichael Marrone, Arnold L Potosky, David Penson, et al.
Frontiers in Genetics|May 1, 2014
Pharmacogenomics in oncology careKelly K Filipski, Leah E Mechanic, Rochelle Long, et al.
Cancer|May 6, 2016
Prediagnostic aspirin use and mortality in women with stage I to III breast cancer: A cohort study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening TrialMarie C Bradley, Amanda Black, Andrew N Freedman, et al.
Breast Cancer Research and Treatment|May 25, 2012
Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010Erika A Waters, Timothy S McNeel, Worta McCaskill Stevens, et al.
Pageof 7